National Lymphangioleiomyomatosis Registry, France
Recruiting now
Conditions studied: Lymphangioleiomyomatosis
In brief
RE-LAM-CE is a registry of lymphangioleiomyomatosis cases in France. its aim is to determine the incidence and prevalence of lymphangioleiomyomatosis in France, including demographic information and information concerning the timing and modalities of diagnosis. Based on the registry, we will set up a prospective cohort of patients. The database will include detailed medical information, particularly regarding progression of the respiratory function.
Key facts
- Study ID
- NCT01484236
- Run by
- Vincent COTTIN
- People needed
- 200
- Starts
- 2012-01-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2025-03-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with sporadic lymphangioleiomyomatosis or associated with Tuberous sclerosis.
- patients diagnosed or hospitalized or seen in consultation since 01/01/2008
You may not qualify if…
- None
Where it is running
- Hôpital Louis Pradel — Lyon, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.